SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Full list of Israeli high-tech funding rounds in 2023

Backslash Security secures $8 million to equip AppSec teams with control over cloud-native applications

daily.dev raises $11 million in Seed funding to build a professional network for developers

"Only when women see themselves as decision makers of the future, will their situation change”

Buzz

Most popular

Daily

Weekly

1

Israeli startup raises $11 million to use generative AI to help developers test their code

2

"Investments in Israel have all but disappeared - also because of the judicial coup”

3

Check Point tells employees no raises in 2023

4

eToro value plummets, raises $250 million at $3.5 valuation

5

TripleW raises $16.5 million Series B to produce lactic acid and bioplastic from food waste

Results

5 stories about Results

גיל שויד מנכל צק פוינט

Check Point solidifies position as Israel's highest-valued company with Q1 results

27.04.22|Sophie Shulman

The cybersecurity powerhouse beat first-quarter forecasts with 7% growth in revenue to $543 million and has seen its valuation climb to $17 billion over recent weeks despite a rocky market

יהודית ימפולסקי סמנכלית משאבי אנוש באמדוקס

Amdocs introduces unlimited vacation policy, registers record revenue

02.02.22|Sophie Shulman

The extra days will be given in coordination with the direct managers and they can be anything from a few single days for errands and up to a week or more for a family visit or any other need

גיל שויד ב כנס חדשנות ב מרכז פרס

Check Point surpasses market forecasts for Q2, recording $217 million profit

The Israeli cybersecurity company’s revenue was up 4% year over year to $526 million, with its cash balance reaching $4 billion. “We’ve seen a 93% increase in ransomware attacks, as Gen V attacks are now the new norm,” said CEO Gil Shwed

קור שולץ מנכ"ל חברת טבע תרופות 23.8.20

Teva reports quarterly profit but shares fall as the group cuts its 2020 revenue outlook

05.11.20|Reuters

Quarterly revenue fell 3% to $3.98 billion, mainly due to lower sales of generic drugs, over-the-counter products and its branded multiple sclerosis treatment Copaxone

בכירי JFrog הנפקה ב בורסה ניו יורק

JFrog eyes continued growth after posting 40% revenue increase in first quarter following Nasdaq IPO

05.11.20|Sophie Shulman

Israeli DevOps technology company reported better-than-expected results, displaying accelerated growth by posting $38.9 million in revenue for the quarter